Royalty Pharma EBIT Margin 2019-2024 | RPRX

Royalty Pharma ebit margin for the quarter ending June 30, 2024 was 42.91%.

  • Royalty Pharma average ebit margin for 2023 was 30.73%, a 25.36% increase from 2022.
  • Royalty Pharma average ebit margin for 2022 was 41.17%, a 41% decline from 2021.
  • Royalty Pharma average ebit margin for 2021 was 69.78%, a 15.99% decline from 2020.

Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Royalty Pharma EBIT Margin 2019-2024 | RPRX

  • Royalty Pharma average ebit margin for 2023 was 30.73%, a 25.36% increase from 2022.
  • Royalty Pharma average ebit margin for 2022 was 41.17%, a 41% decline from 2021.
  • Royalty Pharma average ebit margin for 2021 was 69.78%, a 15.99% decline from 2020.

Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
Related Stocks
Company NameMarket
Cap
American Express (AXP)$191.1B
Blackstone (BX)$115B
Moody's (MCO)$89.2B
Orix Corp Ads (IX)$28B
Brookfield Asset Management (BAM)$21.2B
Grupo Financiero Banorte SAB De CV (GBOOY)$20.9B
Synchrony Financial (SYF)$20.2B
Equitable Holdings (EQH)$13.6B
Jefferies Financial Group (JEF)$12.8B
Daiwa Securities Group (DSEEY)$11.4B
Houlihan Lokey (HLI)$11B
XP (XP)$10.9B
Globe Life (GL)$9.6B
SouthState (SSB)$7.7B
Brookfield Wealth Solutions (BNT)$7.6B
Jackson Financial (JXN)$6.9B
StepStone Group (STEP)$6.2B
Blue Owl Capital (OBDC)$5.8B
Rithm Capital (RITM)$5.8B
Lazard (LAZ)$5.7B
Freedom Holding (FRHC)$5.7B
Virtu Financial (VIRT)$4.9B
Euronet Worldwide (EEFT)$4.5B
HA Sustainable Infrastructure Capital (HASI)$4.1B
AXOS FINANCIAL, INC (AX)$3.9B
Abrdn (SLFPY)$3.7B
PJT Partners (PJT)$3.2B
Community Financial System (CBU)$3.1B
Core Scientific (CORZ)$3B
StoneX Group (SNEX)$2.7B